For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...
The U.S. agency that oversees Medicare is taking out questions on enrollment application forms that ask people about their ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and complex class of genetic ...
Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...
ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...
Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...
Using CRISPR technology, scientists uncovered genes that control C-A-G genetic stumbles in Huntington's disease ...
A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
Cold Fusion on MSN2d
BREAKTHROUGH: Scientists Reverse Blindness [CRISPR Technology]CRISPR Gene editing therapy is used for the first time in living humans with amazing results.
CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback